Roundtable: Discussing the Impact of PEG on Safety & Immunogenicity Studies to Indicate Potential Solutions
Time: 11:30 am
day: Conference Day Two
Details:
- Reviewing how PEG impacts preclinical and clinical safety studies for vaccines, gene and cell therapies
- Discussing solutions and approaches to minimize this impact and generate robust safety data
- Understanding and minimizing unwanted infusion associated reactions stimulated by PEG lipids
- How will PEG lipids impact multi-dosing strategies?
